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Electrophysiological changes caused by inorganic mercury administration during the pre- and/or postnatal development were
studied. Pregnant female Wistar rats were treated, by gavage, with 0.4, 0.8 or 1.6mg/kg mercury (HgCl2 diluted in distilled water):
1/ from day 5 to 15 during pregnancy (P protocol); 2/ from day 5 to 15 of pregnancy + for 4 weeks of lactation (P+L protocol); 3/
from day 5 to 15 of pregnancy + for 4 weeks of lactation, and the offspring were further treated for 8 weeks post-weaning (P+L+P
protocol). Electrophysiological parameters (electrocorticogram, cortical evoked potentials, conduction velocity and refractory peri-
ods of peripheral nerve) of the male offspring from dams in the groups treated according to the above protocols were investigated at
the age of 12 weeks. The rats spontaneous and evoked electrophysiological activity underwent dose- and treatment-dependent
changes following the treatment (increased frequency of spontaneous activity, lengthened latencies and duration of evoked poten-
tials, lower conduction velocity of the peripheral nerve, etc.). In the same rats, however, the treatment failed to cause major signs of
general intoxication. The results emphasize the functional neurotoxic risk arising from the continuous presence of inorganic mercury
in the human environment, and point to possible use of early functional changes for monitoring the effects of mercury.
 2004 Elsevier Ltd. All rights reserved.
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Mercury is one of the heavy metals known to be toxic
for humans and other organisms (WHO, 1991). Origi-
nating from occupational or environmental sources,
mercury is present in different industrial settings, in the
air, as well as in drinking water and food, resulting in
continuous exposure of potentially the whole human
population. The use of elementary mercury or inorganic
mercury salts in various industrial procedures (Kark,
1994) as well as organic (alkyl and aryl) mercury com-
pounds applied as disinfectants and fungicides (Key0278-6915/$ - see front matter  2004 Elsevier Ltd. All rights reserved.
doi:10.1016/j.fct.2004.08.014
* Corresponding author. Tel.: +36 62 545 119; fax: +36 62 545 120.
E-mail address: ppp@puhe.szote.u-szeged.hu (A. Papp).et al., 1977) can be the source of occupational mercury
exposure. On population level, mercury released into
the environment and dental amalgam are major expo-
sure sources (Trepka et al., 1997).
Both inorganic and organic forms of mercury can
cause different neurological disorders. In humans, pares-
thesia, changes of personality and memory loss was ob-
served (Langauer-Lewowiczka and Czapnik, 1986). In
persons occupationally exposed to inorganic mercury,
various disorders of EEG (Piikivi and Tolonen, 1989)
and of evoked responses (Lille et al., 1988; Discalzi
et al., 1993) were observed. By subchronically treating
young adult rats with mercuric chloride, Schulz et al.
(1997) elicited marked alterations of the spontaneous
and evoked cortical activity.
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iments that inorganic mercury passes the blood–brain
barrier and the placental barrier (Aschner and Aschner,
1990). Organic forms of mercury were found to be ex-
creted into the human breast milk (Grandjean et al.,
2003; Plockinger et al., 1993; Sakamoto et al., 2002)
and animal milk (Yoshida et al., 1994; Nielsen and
Anderson, 1995), and to deposit in the human fetus
(Nakai and Satoh, 2002).
In previous studies of our laboratory, several heavy
metals like arsenic (De´si et al., 1998a), lead (Nag-
ymajte´nyi, 1998) or cadmium (De´si et al., 1998b) were
given to rats during phases of ontogenesis, and effects
on the cortical and peripheral electrical activity and on
certain behavioral features were observed. In this work,
our aim was thus the study of neurophysiological effects
of low-dose inorganic mercury in rats treated during
definite phases of pre- and postnatal development.2. Materials and methods
2.1. Animals
The parent generation of the Wistar rats was pur-
chased from the SPF stock of the Research Institute of
Laboratory Animals (Go¨do¨llo¨, Hungary), and was kept
under conventional conditions (up to five rats/cage,
22 ± 2 C, 60 ± 10% humidity, 12h light-dark cycle with
light starting at 6.00 a.m., rodent food and water ad libi-
tum) for three weeks. Then, at the age of 11 weeks, they
were mated (two females and one male per cage).
2.2. Treatment protocols
The treated rats received, by gavage, 0.4, 0.8 or
1.6mg/kg b.w. mercury in form of mercuric chloride
(HgCl2, purity 99.5%, supplied by REANAL, Hungary)
dissolved in distilled water to a 1ml/kg b.w. administra-
tion volume. Control rats were given the same volume of
distilled water. Treatment was done according to one of
the following protocols:
1/Pregnancy (P) protocol: The dams were daily trea-
ted from the 5th to 15th day of pregnancy.
2/Pregnancy + Lactation (P+L) protocol: The dams
were daily treated from the 5th to 15th day of pregnancy
+ during lactation, from the second day after delivery
until separation the offspring at their age of four weeks.
3/Pregnancy + Lactation + Post-weaning (P+L+P)
protocol: The dams were daily treated from the 5th to
15th day of pregnancy + during lactation from second
days after delivery until separation the offspring at their
age of four weeks, + the young male rats after weaning
were treated for further eight weeks in a five days per
week schedule. Each protocol had its own control group,
receiving distilled water in the corresponding periods.In each treatment group, the number and body
weight of the pups was determined within 12h after
birth and the litter size was reduced to eight with up
to five males per litter on the fourth day after parturi-
tion. Thus, at the time of recording, there were alto-
gether 12 groups (3 · 1 control and 3 · 3 treated)
consisting of eight rats each.
Cage side observation of all animals was done contin-
uously during the whole treatment period and symptoms
of intoxication (rough fur, altered motility, unexpected
aggressive behavior, loss of appetite etc.) were noticed.
Body weight was measured weekly. The neurotoxicolog-
ical investigation of the male offspring was performed at
their age of 12 weeks.
2.3. Neurophysiological investigation
The rats were prepared for neurophysiological
recording in urethane (1000.0mg/kg ip.; Bowman and
Rand, 1980) anesthesia (animals treated by the P+L+P
protocol were used on the day following the last admin-
istration). The rats were placed in a stereotaxic instru-
ment, the skull over the left hemisphere was opened,
and silver electrodes were placed on the primary
somatosensory (Par1), visual (Oc1M), and auditory
(Te1) centers (Zilles, 1984). Following a 30min recovery
period, electrocorticogram (ECoG) was recorded from
these cortical areas for 5min. From the record, the soft-
ware (Neurosys 1.11, Experimetria Ltd., UK) deter-
mined the power spectrum, based on the traditional
EEG bands delta to gamma (Kandel and Schwartz,
1985). From the spectrum, the so-called ECoG index
(De´si, 1983), the ratio of the slow and fast bands
[delta + theta/beta1 + beta2] was calculated.
Following the ECoG recording, sensory evoked pot-
entials were recorded from the same cortical sites.
Somatosensory stimulation was done by a pair of steel
needles inserted into the contralateral whisker pad,
delivering square pulses (3–4V, 0.05ms, 1Hz). The vis-
ual system was stimulated by flashes (60 lux, 1Hz) deliv-
ered by a flash bulb unit directly into the contralateral
eye of the rat via a fiber optic conductor. The acoustic
stimuli were clicks (40dB, 0.2ms, 1Hz) produced by a
sound generator in a small earphone put into the ear
of the rat. Fifty evoked potentials of each modality were
recorded, and averaged off-line by means of the above-
mentioned software. Onset latency (of the N1 wave in
case of the somatosensory, N2 wave in case of the visual
and N1 wave in the auditory area) and onset-to-end
duration of the averaged evoked potentials was read
on the screen using the measuring cursors of the
program.
To determine conduction velocity and refractory per-
iod in the tail nerve, a pair of stimulating needle elec-
trodes were inserted at the base of tail, and another
pair, for recording, 50mm distally. Stimulation and
Table 1A
The effect of inorganic mercury treatment, according to the protocols
given in Methods, on the body weight at the time of recording and
dissection
Group Dose (Hg2+, mg/kg b.w.) Body weight (g)
Controla Aqua dest. 398.50 ± 17.841
P 1.6 345.00 ± 41.959
0.8 324.38 ± 10.743
0.4 351.00 ± 35.540
P+L 1.6 363.88 ± 28.134
0.8 361.38 ± 39.713
0.4 339.25 ± 23.644
P+L+P 1.6 372.25 ± 21.763
0.8 371.63 ± 19.464
0.4 368.25 ± 49.505
The data are mean ± SD (n = 8). No significant effects.
a Control of the P+L+P protocol.
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(1998) and De´si et al. (1998a,b).
After finishing the above investigations, the rats were
sacrificed by an overdose of urethane and the weight of
the following organs was measured: brain, liver, heart,
lung, kidneys, thymus and adrenal glands. Relative
organ weights were calculated on the basis of the brain
weight.
During the whole study, the principles of the Ethical
Committee for the Protection of Animals in Research of
the University were strictly followed.
2.4. Statistical evaluation
The distribution of data was checked for normality
by means of the Kolmogorov–Smirnov test. Data anal-
ysis was done by one-way ANOVA. Post hoc analysis of
group differences was performed by a subsequent LSD
test setting the probability level at p < 0.05.3. Results
3.1. General effects
The average number of newborn rats/litter was lower,
especially in the higher dose groups, but the difference
compared to the control was insignificant. The average
body weight at birth of the pups from females receiving
the two higher doses was, in all treatment protocols,
slightly lower. Irrespective of the dose, no macroscopic
malformations were seen. None of the groups, including
that with the high dose P+L+P treatment protocol,
showed movement abnormalities or other clinical signs
of chronic mercury intoxication. The body weight of
the 12 weeks old F1 rats was typically lower in the trea-
ted groups than in the controls but the difference was
not significant (Table 1A). Among the organ weights
(Table 1B), significant increase was seen, in the
P+L+P groups vs. control, in the relative weight of the
liver, thymus and spleen. In other treatment groups
and other organs, no significant effect on organ weights
were seen.
3.2. Electrophysiological effects
3.2.1. Spontaneous cortical activity
On the ECoG, a shift to lower frequencies was seen in
the treated animals. In all doses and treatment proto-
cols, slow wave activity (delta and theta) underwent a
moderate decrease, and the fast waves (beta1 and beta2)
a mild increase, resulting in decrease of the EcoG index.
The extent of change was dependent on dose and time
(determined by the treatment protocol). Treatment with
the two higher doses in the P+L+P protocol resulted,
compared to control, in significantly decreased ECoGindex in the somatosensory area (Table 2A; Fig. 1A).
In the group receiving high dose P+L protocol treat-
ment, the decrease of index was also considerable but
not significant. Likewise, ECoG index in the visual
and auditory centers (Table 2A; Fig. 1B,C) was signifi-
cantly lowered in the highest dose P+L+P groups. In
all other groups, the decrease was not significant. The
alterations of the ECoG frequency bands themselves
were below significance; and the comparison of the
change of ECoG index from the three centers, within
the same treated group vs. control, failed to reveal any
significant difference either.3.2.2. Evoked cortical activity
Mercury treatment caused a dose- and treatment pro-
tocol-dependent lengthening of the latency and duration
of the evoked potentials. Compared to the control, la-
tency of all waves of the somatosensory evoked poten-
tial increased in every treated group. Lengthening of
the N1 wave latency (Table 2B; Fig. 2A), was significant
in the high and middle dose P+L+P groups. A clear but
insignificant prolongation of the duration values was
also seen. Comparing the effect within a dose or a treat-
ment protocol, only negligible differences among the
latencies were seen.
Latency of waves of the visual evoked potential also
underwent a dose-dependent increase in all treatment
variations. The changes of N2 waves (Table 2B; Fig.
2B) were significant in the two high dose P+L+P groups.
In all other treated groups, the changes were insignifi-
cant. Longer durations were observed in all treated
groups but the change was not significant either.
In case of the auditory evoked potential, the latency
of waves was also dose and treatment protocol depend-
ently longer compared to the control. Lengthening of
N1 waves (Table 2B; Fig. 2C) was significant only in
the highest dose groups with P+L+P variation.
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The conduction velocity of the tail nerve was de-
creased in all groups receiving mercury (Table 2C; Fig.
3A) but the difference was significant only with
P+L+P treatment. In these groups, the relative and
absolute refractory periods (Table 2C; Fig. 3B,C) were
also significantly longer. No significant differences be-
tween identical parameters from various treated groups
were seen.4. Discussion
The results of the present work showed that low
doses of inorganic mercury can disturb certain func-
tional processes in central and peripheral nervous sys-
tem, and that the sensitivity of these processes was
dependent on developmental stage. With treatment
according to the P and P+L protocols, the changes of
the investigated forms of spontaneous and evoked activ-
ity were not significant but post-weaning mercury
administration (P+L+P protocol) increased the altera-
tions induced by the pre- and postnatal treatment up
to the level of statistical significance.
In another type of exposure, oral treatment of adult
rats with identical doses as in the present experiment
for 4, 8 or 12 weeks produced dose- and time-dependent
alterations of electrophysiological activity which were
comparable to those seen in the present work (De´si
et al., 1996; Schulz et al., 1997; Papp et al., 2000). A de-
tailed comparison showed, however, that eight weeks
oral exposure after exposure via the mother (P+L+P
protocol) caused significant changes in the tail nerve
parameters with all three doses while the same eight
weeks treatment period in young adult rats without
pre- and postnatal exposure to Hg2+ had significant ef-
fect only with the two higher doses. A similar difference
was also seen on the effect of Hg2+ on the parameters of
cortical activity. Taken together, all this showed that
Hg2+ exposure of the F1 rats during prenatal and early
postnatal development (P and P+L protocols), although
had only minor effects itself, made the rats more vulner-
able to further Hg2+ exposure. The presence of the ef-
fects of P and P+L treatment—with 16 and 8 weeks,
respectively, after the last dose—was also suggested by
the more or less clear trend of increasing alterations
with increasing total treatment length, observable in
Figs. 1–3.
A likely explanation of the lasting effects of mercury
is its dose- and duration-dependent accumulation in the
nervous system during the pre- and postnatal period.
Various forms of mercury can pass the blood–brain bar-
rier (BBB) (Aschner and Aschner, 1990) and the placen-
tal barrier (Clarkson, 1989). In the brain, inorganic
mercury damages the cerebral microvascular endothelial
cells, an essential part of the BBB (Albrecht et al., 1994;
Table 2A
Effects of inorganic mercury treatment, according to the protocols given in Methods, on the ECoG index values
Protocol Dose (Hg2+,
mg/kg b.w.)
ECoG index
SS VIS AUD
P Control 5.88 ± 0.045 4.18 ± 0.03 4.211 ± 0.045
0.4 5.87 ± 0.055 F(3,28) = 1.112 n.s. 4.175 ± 0.036 F(3,28) = 1.453 n.s. 4.201 ± 0.035 F(3,28) = 1.723 n.s.
0.8 5.85 ± 0.04 4.17 ± 0.049 4.18 ± 0.06
1.6 5.805 ± 0.085 4.145 ± 0.04 4.10 ± 0.055
P+L Control 5.86 ± 0.07 4.185 ± 0.051 4.214 ± 0.039
0.4 5.85 ± 0.065 F(3,28) = 1.650 n.s. 4.155 ± 0.045 F(3,28) = 2.021 n.s. 4.185 ± 0.058 F(3,28) = 2.325 n.s.
0.8 5.835 ± 0.075 4.164 ± 0.038 4.125 ± 0.065
1.6 5.77 ± 0.08 4.111 ± 0.064 4.13 ± 0.066
P+L+P Control 5.84 ± 0.05 4.165 ± 0.047 4.222 ± 0.074
0.4 5.845 ± 0.065 F(3,28) = 3.53
p < 0.029
4.140 ± 0.036 F(3,28) = 3.592
p < 0.028
4.17 ± 0.035 F(3,28) = 3.55
p < 0.02850.8 5.79* ± 0.075 4.131 ± 0.06 4.139 ± 0.055
1.6 5.73* ± 0.066 4.075* ± 0.059 4.07* ± 0.075
Data and statistical analysis (one-way ANOVA). The data are mean ± SD (n = 8). Significance: *p < 0.05 vs. control within the same protocol.
(B)   
3.9
4
4.1
4.2
4.3
4.4
P P+L P+L+P
P P+L P+L+P
*
(C)
3.9
4
4.1
4.2
4.3
4.4
P P+L P+L+P
*
5.5
5.6
5.7
5.8
5.9
6
  con 0.4 mg/kg 0.8 mg/kg 1.6 mg/kg
*
*
(A)
Fig. 1. Changes of the ECoG index in the three cortical centers (A—somatosensory; B—visual; C—auditory). Ordinate, index value (mean + SD),
n = 8. Abscissa, treatment protocol. *p < 0.05 vs. control in the same protocol.
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Table 2B
Effects of inorganic mercury treatment, according to the protocols given in Methods, on the latency values of the sensory evoked potentials
Protocol Dose (Hg2+,
mg/kg b.w.)
Evoked potential latency
SS VIS AUD
P Control 8.845 ± 0.04 56.1 ± 3.9 18.6 ± 0 0.5
0.4 8.854 ± 0.036 F(3,28) = 1.546 n.s. 56.5 ± 5.9 F(3,28) = 0.859 n.s. 18.80 ± 0.54 F(3,28) = 1.870
n.s.0.8 8.849 ± 0.054 57.6 ± 5.8 18.90 ± 0.46
1.6 8.870 ± 0.055 56.9 ± 4.1 19.05 ± 0.35
P+L Control .8.841 ± 0.038 56.4 ± 5.2 18.67 ± 0.51
0.4 8.856 ± 0.06 F(3,28) = 1.438 n.s. 57.7 ± 2.8 F(3,28) = 2.548 n.s. 18.88 ± 0.66 F(3,28) = 2.381
n.s.0.8 8.871 ± 0.055 57.6 ± 5.7 19.04 ± 0.24
1.6 8.895 ± 0.044 60.9 ± 2.2 19.40 ± 0.65
P+L+P Control 8.854 ± 0.056 57.2 ± 4.8 18.56 ± 0.45
0.4 8.885 ± 0.039 F(3,28) = 3.221
p < 0.038
58.6 ± 2.9 F(3,28) = 4.87
p < 0.009
19.23 ± 0.58 F(3,28) = 4.14
p < 0.0170.8 8.931* ± 0.054 62.4 ± 6.1 19.29 ± 0.45
1.6 8.966** ± 0.064 63.6** ± 3.8 19.81* ± 0.51
Data and statistical analysis (one-way ANOVA). The data are mean ± SD (n = 8). Significance: *p < 0.05, **p < 0.01 vs. control within the same
protocol.
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through the barriers is limited (Clarkson, 1989) but
there is an oxido-reductive interconversion between
Hg2+ and Hg0 (Clarkson and Rothstein, 1964; Dunn(A)     
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Fig. 2. Changes of the latency of certain evoked potential waves (A—so
Displayed as in Fig. 1; *p < 0.05, **p < 0.01 vs. control in the same protocolet al., 1981) and the metallic form is lipophilic enough
to be permeable. Mercury burden of the mothers organ-
ism (food-borne methyl mercury, dental amalgam etc.)
was shown to pass the placenta and appear in breastL P+L+P
**
*
L P+L+P
**
L P+L+P
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matosensory N1 wave; B—visual N2 wave; C—auditory N1 wave).
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Table 2C
Effects of inorganic mercury treatment, according to the protocols given in Methods, on parameters of the tail nerve
Protocol Dose (Hg2+,
mg/kg b.w.)
Tail nerve parameters
Conduction
velocity
Relative
refractory
period
Absolute
refractory
period
P Control 23.5 ± 0.46 6.39 ± 0.40 0.93 ± 0.024
0.4 23.2 ± 0.35 F(3,28) = 1.549 n.s. 6.39 ± 0.51 F(3,28) = 1.032 n.s. 0.945 ± 0.065 F(3,28) =
0.879 n.s.0.8 23.04 ± 0.44 6.62 ± 0.75 0.94 ± 0.043
1.6 22.95 ± 0.54 6.49 ± 0.59 0.96 ± 0.037
P+L Control 23.45 ± 0.33 6.30 ± 0.55 0.92 ± 0.072
0.4 22.8 ± 0.64 F(3,28) = 2.254 n.s. 6.65 ± 0.75 F(3,28) = 2.436 n.s. 0.96 ± 0.05 F(3,28) =
1.652 n.s.0.8 22.75 ± 0.76 6.79 ± 0.66 0.985 ± 0.085
1.6 22.06 ± 0.87 6.82 ± 0.85 0.99 ± 0.041
P+L+P Control 23.6 ± 0.35 6.33 ± 0.33 0.94 ± 0.036
0.4 22.33* ± 0.26 F(3,28) = 5.81
p < 0.0039
6.72* ± 0.65 F(3,28) = 5.17
p < 0.0068
1.00* ± 0.054 F(3,28) = 6.58
p < 0.002
0.8 22.15**± 0.44 7.03** ± 0.75 1.01* ± 0.075
1.6 21.54** ± 0.75 7.06** ± 0.84 1.035** ± 0.063
Data and statistical analysis (one-way ANOVA). The data are mean ± SD (n = 8). Significance: *p < 0.05, **p < 0.01 vs. control within the same
protocol; p < 0.05 vs. lower doses within the same protocol.
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Fig. 3. Changes in the functional parameters of the tail nerve (A—conduction velocity; B—relative refractory period; C—absolute refractory
period). Displayed as in Fig. 2; p < 0.05 vs. lower doses within the same protocol.
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babies can be exposed this way for several months
(Grandjean et al., 2003; Oskarsson et al., 1995, 1996).
Following human exposure to inorganic mercury in
miners, deposited Hg was found in the postmortem dis-
sected brains (Kosta et al., 1975). Within the rat brain,
mercury is deposited primarily in the neocortex, the basal
ganglia and also in the cerebellar Purkinje cells (Warf-
vinge et al., 1992), as well as in the thalamus and in the
spinal cord (Mo¨ller-Madsen, 1990). Although mercury
content was not measured in our study, the increasing ex-
tent of the changes in the groups treated for longer peri-
ods might correspond to the accumulation mechanism.
Mercury, when present in the nervous system, affects
the bioelectric processes of nerve cells by influencing the
operation of voltage-activated Ca2+-channels and the re-
lease or turnover of neurotransmitters, resulting finally
in disturbed neuronal cation homeostasis (Rajanna
and Hobson, 1985; Hare et al., 1990; Narahashi et al.,
1994; Weinsberg et al., 1995; Denny and Atchison,
1996; Sirois and Atchinson, 1996).
In long-term occupational exposure to inorganic mer-
cury, alterations of the cortical electrical activity have
been reported. Slowed EEG was found (in chloralkali
workers; Piikivi and Tolonen, 1989), as well as ampli-
tude increase of the somatosensory evoked potential
(Lille et al., 1988) and delayed waves in the brainstem
auditory evoked potential (Discalzi et al., 1993). The
excitatory input producing evoked activity is glutamat-
ergic. Uptake of glutamate by astrocytes, a major factor
in terminating its excitatory, and potentially excitotoxic,
action (McBean and Roberts, 1985; Robinson et al.,
1993) is inhibited by HgCl2 at low doses (Brookes,
1988). In rats treated for 12 weeks with the same Hg2+
doses as in the present study (Papp et al., 2000; Schulz
et al., 1997), decreased EP amplitudes were seen, possi-
bly due to the excitotoxicity of excess glutamate for a
longer time. The effects of mercury on certain modulator
mechanisms of cortical activity (cholinergic: Castoldi
et al., 1996; dopaminergic: Faro et al., 2001) also may
have contributed to the increased high-frequency activ-
ity and, indirectly, the depression of evoked responses
(Re´mond and Lese´vre, 1967).
Damage to axons by HgCl2, as described by Pam-
phlett and Coote (1998), and the above-mentioned ef-
fects of Hg2+ on ion channels and Ca2+ homeostasis
(Denny and Atchison, 1996; Sirois and Atchinson,
1996) may result in impaired action potential generation
and conduction. In our study, the tail nerve action
potential proved to be the most sensitive to Hg2+ expo-
sure during development by showing significant changes
in the P+L+P protocol with 0.4mg/kg dose. The Toxico-
logical Profile for Mercury (ATSDR, 1999) lists several
NOAEL and LOAEL doses for rats in subchronic expo-
sure. The lowest NOAEL listed was 0.23, and the
LOAEL, 0.46mg/kg; derived from renal pathology(Dieter et al., 1992). Compared to that, peripheral nerve
activity seem to be an equally sensitive endpoint, and
can be assessed by standard non-invasive methods.
Epidemiological investigations published up to now
(although all were concerned with the consequences of
chronic environmental organic mercury exposure: Dol-
bec et al., 2000; Ely, 2001; Myers et al., 1997) suggest
the necessity of developing some behavioral and/or
physiological biomarkers which—beyond the widely
used biochemical monitoring—can be followed-up in
the affected population by means of sensitive, non-inva-
sive screening methods. Based on the results presented
above, evoked peripheral nerve activity is a possible can-
didate for such a functional biomarker.Acknowledgment
The work was supported by the Hungarian grants
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